The Future of Addiction Treatment Starts Here: GLP-1s Explained With Dr. Ken Spielvogel

On this episode of We’re Out Of Time, host Richard Taite sits down with Dr. Ken Spielvogel, Senior Medical Officer at Carrera Treatment Wellness & Spa, to explore one of the most talked-about breakthroughs in addiction medicine: GLP-1 medications. Originally developed for diabetes and weight loss, emerging research now suggests GLP-1s may significantly reduce cravings, compulsive behavior, and relapse risk in people struggling with substance use disorders. Dr. Spielvogel explains how GLP-1 medications are being used in addiction treatment, including why injectable options outperform oral medications when it comes to compliance and effectiveness. The conversation breaks do...